TLR4 and acute respiratory distress syndrome: ALI is characterized by a local inflammatory response, and the potential efficacy of TLR4 mAb to treat ALI is based on the hypothesis that TLR4 mAb suppresses the TLR4-associated inflammatory cascade of ALI.